Intellicheck, Inc.

  • Market Cap: Micro Cap
  • Industry: Software Products
  • ISIN: US45817G2012
USD
6.45
0.29 (4.71%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Intellicheck, Inc. stock-summary
stock-summary
Intellicheck, Inc.
Software Products
Intellicheck, Inc. is a technology company. The Company is engaged in developing, integrating and marketing threat identification and identity authentication solutions for various applications, including retail fraud prevention, law enforcement threat identification, and mobile and handheld access control and security for the government, military and commercial markets. Its products include Retail ID, a solution for preventing fraud in the retail industry; Age ID, a smartphone or tablet-based solution for preventing sale of age-restricted products to minors; and Defense ID, a mobile and fixed infrastructure solution for threat identification, identity authentication and access control to military bases and other government facilities. The Company’s identity systems are marketed to the Commercial and Government identification sectors.
Company Coordinates stock-summary
Company Details
535 Broadhollow Rd Ste B51 , MELVILLE NY : 11747-3720
stock-summary
Tel: 1 516 99219001 949 8732789
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 8 Schemes (6.67%)

Foreign Institutions

Held by 10 Foreign Institutions (5.33%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Guy Smith
Independent Chairman of the Board
Mr. Bryan Lewis
President, Chief Executive Officer, Director
Lt. Gen Emil Bedard
Independent Director
Maj. Gen. Jack Davis
Independent Director
Mr. William Georges
Independent Director
Mr. Dylan Glenn
Independent Director
Dr. Amelia Ruzzo
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
5 Million
(Quarterly Results - Jun 2025)
Net Profit:
0 Million
stock-summary
Industry

Software Products

stock-summary
Market cap

USD 112 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.48

stock-summary
Return on Equity

-5.10%

stock-summary
Price to Book

6.23